Developing novel agents to prevent tumour recurrence in glioblastoma [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Glioblastoma is a form of brain cancer that is currently incurable. We have discovered that switching-off an enzyme called KDM4 (using 'KDM4 inhibitors') improves chemotherapy outcomes with new drugs also discovered in our laboratory. This project will examine a novel drug combination treatment for glioblastoma patients and generate evidence for initiation of clinical trials. This could initiate a novel therapy that could significantly extend patients' lives.

Funding Amount $1,089,561

Funding Scheme Ideas Grants

Chief Investigator A/Pr Lenka Munoz

Notes Ideas Grants